Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesNeurology/Neurosurgeryorthonet EDX Coverage & Prior Auth Policy Update |…
    Ask Trek AI about this page
    CurrentorthonetPolicy 359

    Electrodiagnostic Testing (EDX) — NCV/NCS, Needle EMG, SSEP

    Customize your policy alerts

    Sign up for orthonet Policy 359 alerts

    Get alerted when Policy 359 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical criteria governing the appropriate use and medical necessity of electrodiagnostic testing (NCV/NCS, needle EMG, SSEP) for evaluation of neuromuscular disorders; applies to in- and out-of-network programs (excludes Medicare/Medicaid chiropractic products).

    Policy Summary
    Payerorthonet
    PolicyElectrodiagnostic Testing (EDX) — NCV/NCS, Needle EMG, SSEP
    Policy CodePolicy 359
    Change TypeNo material change
    Effective DateApr 30, 2026
    Last ReviewApr 30, 2026
    Next Review DateApr 30, 2026
    Key ActionDocument medical necessity and the need/scope of the study in the patient's medical record following a comprehensive history and neurologic/neuromuscular exam.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    359
    Policy ID
    EDX = NCV + EMGGold standard
    65%SSEP false-negative
    ~20CPT codes listed
    AANEMReferences

    Coverage Criteria for Electrodiagnostic Testing

    Medically necessary EDX testing conditions

    Covered when ALL of the following are met

    EDX general coverage: Electrodiagnostic testing (EDX) is considered a proven method for assessing patients with neuromuscular or suspected neuromuscular disorders (myopathies, neuropathies, neuromuscular junction disorders, nerve compression syndromes, plexopathies) when clinically indicated and guided by a comprehensive history and neurologic (and neuromuscular) examination.

    See supporting examples and test-specific rules.

    SSEP proven indications: Somatosensory evoked potential (SSEP) testing is considered proven for: intraoperative monitoring during spinal scoliosis surgery; suspected brain or spinal cord trauma; coma; diabetic peripheral neuropathy; multiple sclerosis; myoclonus; nontraumatic spinal cord lesions (e.g., cervical spondylosis or myelopathy); spinocerebellar degeneration; and subacute combined degeneration of the spinal cord.

    SSEP for other disorders is unproven.

    NCS without EMG exceptions: Nerve conduction studies (NCV/NCS) performed without concurrent needle electromyography (EMG) are supported only when the patient is: receiving anticoagulant therapy or has bleeding/clotting disorders; has lymphedema; reports susceptibility to recurrent systemic infections; or is being evaluated for carpal tunnel syndrome.

    Outside these circumstances, NCS without EMG are considered unproven.

    Concurrent testing standard: In the absence of contraindications, concurrent needle EMG and NCS (same session or within two business days) are the gold standard and should be performed together; dissociation into separate reports is generally inappropriate unless specifically explained.

    NCS are usually performed first and concurrently followed by needle EMG; EMG complements NCS.

    Unproven or Not Medically Necessary

    Considered unproven / not medically necessary when ANY of the following apply

    Unproven or not medically necessary: Electrodiagnostic testing is unproven (not medically necessary) when: performed for screening purposes; performed absent a comprehensive history and complete neuromuscular exam; performed after a definitive diagnosis has been established; NCV/NCS are performed without concurrent needle EMG except in the specific exceptions listed; use of dermatomal/segmental SSEP testing for lumbosacral radiculopathy; use of F-wave or H-reflex testing when performed without concurrent needle EMG and motor and sensory NCS.

    There is a high false-negative rate for SSEP in lumbar radiculopathy and inconsistent evidence for DSEP testing.

    This policy applies to electrodiagnostic testing utilization review determinations for in-network and out-of-network programs. It explicitly excludes Medicare and Medicaid chiropractic products from its scope of applicability; providers billing under those products should follow applicable Medicare/Medicaid coverage rules instead.

    The policy history documents periods of inactivation and subsequent reinstatement and multiple annual reviews, but the cited review history entries do not introduce additional explicit exclusion criteria beyond those stated in the Scope. Review and approval history should be consulted for versioning and administrative context, however it does not themselves list clinical exclusions beyond scope notes.

    When performed with other studies, short-latency somatosensory evoked potentials (SSEP) are considered proven only for the listed central nervous system and perioperative indications; SSEP for disorders not listed is unproven/not medically necessary, and SSEP has a reported high false-negative rate (~65%) for lumbar radiculopathy so dermatomal/segmental SSEP (DSEP) is not supported for lumbosacral radiculopathy.

    F-wave and H-reflex (late response) testing are commonly performed alongside nerve conduction studies but lack sufficient clinical utility when done in isolation; these late responses are not supported for diagnostic conclusions if performed without concurrent needle EMG and motor and sensory NCS.

    Nerve conduction velocity/studies (NCV/NCS) may be performed without concurrent needle EMG only in specific circumstances (e.g., patients on anticoagulation, with bleeding/clotting disorders, with lymphedema, susceptible to recurrent systemic infections, or when evaluating carpal tunnel syndrome); outside those exceptions, NCV/NCS without concurrent needle EMG is considered unproven/not medically necessary.

    Coding Information

    EDX CPT Codes (examples listed)CPT
    95860Needle electromyography; 1 extremity with or without related paraspinal areas.
    95861Needle electromyography; 2 extremities with or without related paraspinal areas.
    95863Needle electromyography; 3 extremities with or without related paraspinal areas.
    95864Needle electromyography; 4 extremities with or without related paraspinal areas.
    95885Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure).
    95886Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal levels (List separately in addition to code for primary procedure).
    95907Nerve conduction studies; 1-2 studies.
    95908Nerve conduction studies; 3-4 studies.
    95909Nerve conduction studies; 5-6 studies.
    95910Nerve conduction studies; 7-8 studies.
    1–10 of 17
    1/2
    Covered CPT Codes (listed in policy coding section)CPTCovered
    95860Needle electromyography; 1 extremity with or without related paraspinal areas.
    95861Needle electromyography; 2 extremities with or without related paraspinal areas.
    95863Needle electromyography; 3 extremities with or without related paraspinal areas.
    95864Needle electromyography; 4 extremities with or without related paraspinal areas.
    95885Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure).
    95886Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal levels (List separately in addition to code for primary procedure).
    95907Nerve conduction studies; 1-2 studies.
    95908Nerve conduction studies; 3-4 studies.
    95909Nerve conduction studies; 5-6 studies.
    95910Nerve conduction studies; 7-8 studies.
    1–10 of 17
    1/2
    Prior Authorization

    Prior authorization / utilization management for listed CPT codes

    Certain CPT codes for needle EMG, nerve conduction studies, and somatosensory evoked potentials listed in the policy are subject to utilization management and may require prior authorization per payer procedures; follow your payer's prior authorization process for these services.

    • Covered/managed CPT codes include: 95860, 95861, 95863, 95864, 95885, 95886, 95907–95913, 95925–95927, and 95999 (as listed in the Coding Information).
    • Policy governs utilization review for in- and out-of-network programs (excludes Medicare and Medicaid chiropractic products) and was updated to add a Documentation section on 04/22/2021.

    Provider Actions, Documentation, and Prior Authorization

    Prior Authorization

    Prior authorization applies to in‑ and out‑of‑network programs

    This policy governs utilization review determinations for both in-network and out-of-network programs (excluding Medicare and Medicaid chiropractic products); follow the payer's prior authorization process when requesting EDX services.

    Step Therapy

    Testing sequence — perform NCS first, then needle EMG

    Nerve conduction studies (NCS) are usually performed first and are followed by needle electromyography (EMG); EMG complements NCS and should be performed (concurrently or within two business days) unless contraindicated.

    • Dissociation of NCS and EMG into separate reports is inappropriate unless specifically explained by the physician.

    Definitions and Test Descriptions

    Electrodiagnostic testing — definition
    DefinitionRecording, by needle and/or surface electrodes, and evaluation of electrical activity within the neuromuscular system; includes needle electromyography (EMG), nerve conduction velocity/studies (NCS/NCV), and somatosensory evoked potential testing (SSEP).
    Electrode typesNeedle and/or surface electrodes used to record neuromuscular electrical activity.
    Included test typesNeedle EMG, nerve conduction velocity/studies (NCV/NCS), and somatosensory evoked potentials (SSEP).
    Clinical useUsed to assess myopathies, neuropathies, neuromuscular junction disorders, nerve compression syndromes, plexopathies, radiculopathies, motor neuron disease, and certain CNS lesions.
    Concurrent NCV/EMG testing — definition and timing
    Definition

    Background

    Electrodiagnostic (EDX) testing documents electrical activity of the neuromuscular system and encompasses needle electromyography (EMG), nerve conduction studies (NCS/NCV), and somatosensory evoked potentials (SSEP). The exam is intended to extend a comprehensive history and neurological/neuromuscular examination and should be individualized and designed by a clinician knowledgeable in neurophysiology.

    Needle EMG evaluates muscle electrical activity using needle electrodes and is described by CPT codes such as 95860–95864 and 95885–95886. Nerve conduction studies assess peripheral nerve function and are represented by CPT codes 95907–95913. Short-latency SSEP studies are represented by CPT codes 95925–95927 and assess afferent pathway integrity.

    In routine practice, NCS are usually performed first and, unless contraindicated, should be performed concurrently with needle EMG (same session or within two business days) because the combination provides the gold-standard electrodiagnostic evaluation.

    Policy Revision History

    2007-03-08inactivation_approved

    Utilization Management Committee approved inactivation of the policy.

    2008-12-11policy_revised

    Policy revised: retitled (Electrodiagnostic Testing), reformatted, and submitted to the Utilization Management Committee for approval.

    2009-01-15revision_approved

    Revised policy approved by the Quality Improvement Committee.

    Policy Summary
    Payerorthonet
    PolicyElectrodiagnostic Testing (EDX) — NCV/NCS, Needle EMG, SSEP
    Policy CodePolicy 359
    Change TypeNo material change
    Effective DateApr 30, 2026
    Last ReviewApr 30, 2026
    Next Review DateApr 30, 2026
    Key ActionDocument medical necessity and the need/scope of the study in the patient's medical record following a comprehensive history and neurologic/neuromuscular exam.
    SourceLink
    On This Page
    Coverage Criteria for Electrodiagnostic TestingCoding InformationProvider Actions, Documentation, and Prior AuthorizationDefinitions and Test DescriptionsBackgroundPolicy Revision History
    Billing Rule

    Provider billing action: document exceptions and use listed CPT codes

    When ordering or billing EDX studies, ensure codes and services reflect the combined diagnostic approach (NCS + EMG) and any listed exceptions for NCS without EMG are documented.

    • If NCS is performed without EMG, document an approved exception (e.g., anticoagulation, lymphedema, recurrent infections, carpal tunnel evaluation).
    • Use the appropriate CPT codes from the policy coding list when submitting claims.
    Documentation Required

    Document medical necessity in the medical record

    Medical necessity for the electrodiagnostic procedure(s) must be documented and supported in the patient's medical record, including the need and scope of the study following a comprehensive history and neurological/neuromuscular exam.

    Documentation Required

    Maintain complete EDX exam documentation

    Providers should retain supporting documentation for electrodiagnostic studies as referenced in the policy (documentation section added 04/22/2021).

    • Keep records of the comprehensive history, neurologic exam, and EDX study findings and interpretations.
    Denial Risk

    Triggers for denial — screening, missing exam/history, post‑diagnosis, NCS without EMG

    EDX studies performed for screening purposes, lacking a comprehensive history and complete neuromuscular exam, performed after a definitive diagnosis is established, or NCS performed without concurrent needle EMG (outside listed exceptions) are considered unproven and may be denied.

    • Dermatomal/segmental SSEP for lumbosacral radiculopathy and sole use of F‑wave/H‑reflex without EMG/NCS are unproven and subject to denial.
    Denial Risk

    Denial risk from noncompliance with policy and documentation

    Absence of required documentation or nonconformance with coding and policy guidance may trigger utilization management actions; the policy is reviewed periodically and noncompliance can lead to denial or other review outcomes.

    • Maintain documentation consistent with policy expectations and coding lists to avoid review actions.
    Performance of NCV/nerve conduction studies together with needle electromyography during the same session or within two business days of each other.
    Preferred sequenceNerve conduction studies are usually performed first and are concurrently followed by needle EMG, unless contraindicated.
    Documentation noteDissociation into separate reports or delays beyond two business days is generally inappropriate unless clinically explained.
    Needle electromyography — CPT examples
    Representative CPT codes95860, 95861, 95863, 95864 — Needle electromyography for 1–4 extremities (with or without related paraspinal areas).
    Add-on CPT codes95885 — Needle EMG, limited, with nerve conduction (list separately); 95886 — Needle EMG, complete (five or more muscles), with nerve conduction (list separately).
    Clinical purposeEMG evaluates peripheral nerves, nerve roots, and muscle for evidence of denervation, reinnervation, and myopathic or neuropathic processes.
    Nerve conduction studies — CPT examples
    Representative CPT codes95907, 95908, 95909, 95910, 95911, 95912, 95913 — Nerve conduction studies for 1–13+ studies (grouped increments).
    Code descriptions95907: 1–2 studies; 95908: 3–4 studies; 95909: 5–6 studies; 95910: 7–8 studies; 95911: 9–10 studies; 95912: 11–12 studies; 95913: 13 or more studies.
    Use guidanceNCS quantify peripheral nerve conduction (amplitude, latency, velocity) and are typically performed before EMG to guide testing.
    Somatosensory evoked potentials (SSEP) — CPT examples
    Representative CPT codes95925, 95926, 95927 — Short-latency somatosensory evoked potential (SSEP) studies for upper limbs, lower limbs, and trunk/head respectively.
    Code descriptions95925: upper limbs; 95926: lower limbs; 95927: trunk or head — stimulation of peripheral nerves/skin sites with CNS recording.
    Indications noteSSEP is indicated for intraoperative monitoring, evaluation of spinal cord and certain CNS disorders; other uses are limited per policy guidance.
    2009-04-30annual_review

    Annual review and approval completed.

    2013-04-18annual_review_and_update

    Annual review and approval completed; updated section describing circumstances where NCV is appropriate.

    2021-04-22annual_review_and_update

    Annual review and approval completed; Documentation section was added and References/Table 1 updated.

    2023-04-27annual_review

    Annual review and approval completed; no significant clinical changes made and contact email updated.

    2024-02-14annual_review_and_template_transition

    Annual review completed; document content transitioned to a new policy template with no substantive clinical changes; approved by the Optum Clinical Guideline Advisory Committee.

    2026-04-30annual_reviewLatest

    Annual review completed with no substantive changes; approved by the Optum Quality Improvement Committee.